# Tchéquie – Immunosuppresseurs – Selektivní imunosupresiva - Imlifidasa IV.

Acheteur : Institut klinické a experimentální medicíny.  Pays : Tchéquie.  CPV : 33652300.

Source: QUOTA CÔTE — https://quotacote.com/opportunites/tchequie-immunosuppresseurs-selektivni-imunosupresiva-imlifidasa-iv-tc--00ab15e8-a101-4987-97e7-29a1c9dec757
Last checked by QUOTA: 2026-09-28
Methodology: https://quotacote.com/a-propos-des-donnees

## Key facts

- Country: Tchéquie [FACT]
- Deadline: 2026-08-17 [FACT]
- Last checked by QUOTA: 2026-09-28 [FACT]
- Sector (QUOTA normalisation): Autre [ANALYSIS]
- Summary: QUOTA editorial summary of the source notice [ANALYSIS]

## Entities

- geography: Tchéquie
- funder: Institut klinické a experimentální medicíny
- buyer: Institut klinické a experimentální medicíny

## Limitations

- QUOTA republishes a normalised summary, not the tender documents themselves.
- Commercial details (source dossier, full deadline history, budget) are reserved for subscribers.